[{"address1": "1375 West Fulton Street", "address2": "Suite 1300", "city": "Chicago", "state": "IL", "zip": "60607", "country": "United States", "phone": "844 445 5704", "website": "https://www.xerispharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Xeris Biopharma Holdings, Inc., a commercial-stage biopharmaceutical company, engages in developing and commercializing therapies for chronic endocrine and neurological diseases in Illinois. The company offers Gvoke, a ready-to-use liquid-stable glucagon for the treatment of severe hypoglycemia in pediatric and adult patients; Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It is also developing XP-8121, a once-weekly subcutaneous injection of levothyroxine that is in phase 3 clinical trial for the treatment of hypothyroidism. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.", "fullTimeEmployees": 394, "companyOfficers": [{"maxAge": 1, "name": "Mr. John P. Shannon", "age": 62, "title": "CEO & Director", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 1065572, "exercisedValue": 0, "unexercisedValue": 341267}, {"maxAge": 1, "name": "Mr. Kevin  McCulloch", "age": 60, "title": "President & COO", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 777048, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steven M. Pieper", "age": 46, "title": "Chief Financial Officer", "yearBorn": 1978, "fiscalYear": 2024, "totalPay": 747017, "exercisedValue": 30004, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Beth P. Hecht J.D.", "age": 60, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 767825, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Paul R. Edick J.D.", "age": 68, "title": "Senior Advisor", "yearBorn": 1956, "fiscalYear": 2024, "totalPay": 2597639, "exercisedValue": 0, "unexercisedValue": 1357712}, {"maxAge": 1, "name": "Ms. Allison  Wey", "title": "Senior Vice President of Investor Relations & Corporate Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Brian  Conner", "title": "SVP of Quality and Chief Compliance & Risk Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kendal  Korte", "title": "Senior Vice President of Human Resources", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anh  Nguyen M.B.A., M.D.", "age": 49, "title": "Chief Medical Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 7, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.6, "open": 6.65, "dayLow": 6.54, "dayHigh": 6.93, "regularMarketPreviousClose": 6.6, "regularMarketOpen": 6.65, "regularMarketDayLow": 6.54, "regularMarketDayHigh": 6.93, "payoutRatio": 0.0, "beta": 0.86, "forwardPE": -31.09091, "volume": 11392461, "regularMarketVolume": 11392461, "averageVolume": 2362301, "averageVolume10days": 4054540, "averageDailyVolume10Day": 4054540, "bid": 6.77, "ask": 6.86, "bidSize": 5, "askSize": 12, "marketCap": 1104523264, "fiftyTwoWeekLow": 2.21, "fiftyTwoWeekHigh": 7.09, "priceToSalesTrailing12Months": 4.4894757, "fiftyDayAverage": 4.967, "twoHundredDayAverage": 4.1892, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 1302463744, "profitMargins": -0.13006, "floatShares": 154021589, "sharesOutstanding": 161480000, "sharesShort": 19554170, "sharesShortPriorMonth": 17940320, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.1221, "heldPercentInsiders": 0.04137, "heldPercentInstitutions": 0.5517, "shortRatio": 8.78, "shortPercentOfFloat": 0.127, "impliedSharesOutstanding": 161859008, "bookValue": -0.12, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -31999000, "trailingEps": -0.29, "forwardEps": -0.22, "enterpriseToRevenue": 5.294, "enterpriseToEbitda": 155.611, "52WeekChange": 2.04, "SandP52WeekChange": 0.19554341, "quoteType": "EQUITY", "currentPrice": 6.84, "targetHighPrice": 11.0, "targetLowPrice": 6.0, "targetMeanPrice": 7.8, "targetMedianPrice": 7.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 59285000, "totalCashPerShare": 0.367, "ebitda": 8370000, "totalDebt": 257223008, "quickRatio": 1.18, "currentRatio": 1.95, "totalRevenue": 246024992, "revenuePerShare": 1.613, "returnOnAssets": -0.00698, "grossProfits": 202328000, "revenueGrowth": 0.488, "grossMargins": 0.82238996, "ebitdaMargins": 0.03402, "operatingMargins": 0.062649995, "financialCurrency": "USD", "symbol": "XERS", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1754694074, "regularMarketTime": 1754683200, "shortName": "Xeris Biopharma Holdings, Inc.", "longName": "Xeris Biopharma Holdings, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1529587800000, "postMarketChangePercent": -0.282164, "postMarketPrice": 6.8207, "postMarketChange": -0.0193, "regularMarketChange": 0.24, "regularMarketDayRange": "6.54 - 6.93", "fullExchangeName": "NasdaqGS", "cryptoTradeable": false, "averageDailyVolume3Month": 2362301, "fiftyTwoWeekLowChange": 4.63, "fiftyTwoWeekLowChangePercent": 2.0950227, "fiftyTwoWeekRange": "2.21 - 7.09", "fiftyTwoWeekHighChange": -0.25, "fiftyTwoWeekHighChangePercent": -0.03526093, "fiftyTwoWeekChangePercent": 204.0, "earningsTimestamp": 1754539200, "earningsTimestampStart": 1762518600, "earningsTimestampEnd": 1762518600, "earningsCallTimestampStart": 1754569800, "earningsCallTimestampEnd": 1754569800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.29, "epsForward": -0.22, "epsCurrentYear": -0.09, "priceEpsCurrentYear": -76.0, "fiftyDayAverageChange": 1.8730001, "fiftyDayAverageChangePercent": 0.37708881, "twoHundredDayAverageChange": 2.6508002, "twoHundredDayAverageChangePercent": 0.63277006, "priceToBook": -57.000004, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.4 - Strong Buy", "exchange": "NMS", "messageBoardId": "finmb_105901792", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 3.63637, "regularMarketPrice": 6.84, "displayName": "Xeris Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-08-09"}]